BAVARIAN NORDIC R/I S/ADR (BVNRY) analyst actions
Rating and price-target actions on BVNRY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BVNRY overview →
2 measured BVNRY analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance | Press release | +0.02% | -0.52% | |
| Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate | Press release | +0.00% | +1.12% |
Keep exploring
More BVNRY: earnings → · SEC filings → · BVNRY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
| CYTODYN INC (CYDY) | 191 | -0.07% | 45% |
| U S STEM CELL INC (USRM) | 190 | 0.00% | 37% |
| InnovAge Holding Corp. (INNV) | 189 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.